We studied the scientific literature and disease guidelines in order to summarize the clinical utility of genetic testing for Senior- Loken syndrome (SLSN). SLSN is inherited in an autosomal recessive manner, has a prevalence of one in a million, and is caused by variations in CEP164, CEP290, INVS, IQCB1, NPHP1, NPHP3, NPHP4, SDCCAG8, TRAF3IP1 and WDR19 genes. Clinical diagnosis is based on kidney (urine analysis, abdominal ultrasound, kidney function) and eye assessment (visual acuity test, fundus examination, refraction defects, color testing and electroretinography). The genetic test is useful for confirming diagnosis, and for differential diagnosis, couple risk assessment and access to clinical trials.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Loken AC Hanssen O Halvorsen S Jolster NJ. Hereditary renal dysplasia and blindness. Acta Paediatr. 1961 Mar; 50:177-84. PubMed PMID: 13763238
2. Delaney V Mullaney J Bourke E. Juvenile nephronophthisis congenital hepatic fibrosis and retinal hypoplasia in twins. Q J Med. 1978 Jul; 47(187):281-90. PubMed PMID: 568809
3. Chen B Gagnon M Shahangian S Anderson NL Howerton DA Boone JD. Good laboratory practices for molecular genetic testing for heritable diseases and conditions. MMWR Recomm Rep. 2009 Jun 12; 58(RR-6):1-37. PubMed PMID: 19521335.
4. Stone EM Aldave AJ Drack AV Maccumber MW Sheffield VC Traboulsi E Weleber RG. Recommendations for genetic testing of inherited eye diseases: report of the American Academy of Ophthalmology task force on genetic testing. Ophthalmology. 2012 Nov; 119(11):2408-10. PubMed PMID: 22944025. Epub 2012/09/01.